Riskpilot← Back to searchSign inGet full accessGradientti Oy
OYDissolvedY-tunnus 2110901-3C/O Arto Kulju Ratsumiehenkatu 5Medical specialists activities · NACE 8622Est. 20072 employees
Revenue 2024
EUR 148,7M
+9825% vs 2023
EBITDA margin
11.0%
+9112% vs 2023
Equity ratio
98.7%
Financial strength
Net profit 2024
EUR 16,4M
+11571% vs 2023
| Revenue | EUR 148,7M | +9825% |
| EBITDA | EUR 16,4M | +9112% |
| Net profit | EUR 16,4M | +11571% |
| Total assets | EUR 100,6M | +10895% |
| Equity | EUR 99,3M | +10918% |
| Employees | 2 | — |
Legal name
Gradientti Oy
Y-tunnus number
2110901-3
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
17. huhtikuuta 2007
Share capital
EUR 2 500
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on lääketieteellinen koulutus ja konsultointi sekä muut alaan liittyvät terveydenhoidolliset palvelut. Lisäksi yhtiö voi ostaa, omistaa ja myydä osakkeita ja osuuksia sekä harjoittaa sijoitustoimintaa. Yritys voi toimintaansa varten omistaa osakkeita, osuuksia sekä kiinteistöjä. Lisäksi yhtiö voi ostaa, vuokrata ja myydä toimialoihinsa liittyviä koneita, laitteita ja ohjelmistoja.
Address
C/O Arto Kulju Ratsumiehenkatu 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 1 313 | 1 242 | 1 044 | 1 405 | 1 498 | 148 683 |
| Staff expenses | −199 | −148 | −146 | −139 | −144 | −14 624 |
| EBITDA | 122 | 129 | 109 | 135 | 178 | 16 402 |
| Depreciation & amort. | −9 | −16 | −12 | −7 | −5 | −374 |
| EBIT | 113 | 113 | 97 | 128 | 173 | 16 029 |
| Net financials | 3 | 4 | 3 | 0 | 2 | 4 037 |
| Profit before tax | 116 | 117 | 100 | 128 | 176 | 20 066 |
| Tax | 29 | 23 | 15 | 26 | 35 | 37 |
| Net profit | 87 | 94 | 86 | 102 | 140 | 16 388 |
| Item | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 686 | 723 | 749 | 838 | 915 | 100 650 |
| Equity | 674 | 714 | 742 | 827 | 901 | 99 318 |
| Long-term debt | — | — | — | — | 0 | 0 |
| Short-term debt | 13 | 9 | 7 | 11 | 14 | 1 332 |
| Total debt | 13 | 9 | 7 | 11 | 14 | 1 332 |
EBITDA margin
11.0%
This company
15.8%
Market median
-30% vs market
20182024
Equity ratio
98.7%
This company
38.2%
Market median
+158% vs market
20182024
Return on equity
16.5%
This company
18.4%
Market median
+10% vs market
20182024
Net profit margin
11.0%
This company
8.1%
Market median
+36% vs market
20182024
Asset turnover
1.48×
This company
1.12×
Market median
+32% vs market
20182024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20182024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SI Deputy Member | Deputy Member | 2007 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2007 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Gradientti Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sari Irina Itälinna | Deputy Member | 0 companies |
| Arto Tapio Kulju | Board of Directors | 0 companies |